Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Genotyping Panels Detect Polymorphisms and Gene Variants

By LabMedica International staff writers
Posted on 09 Apr 2009
Genotyping panels are specific multiplexes that detect polymorphisms and gene variants associated with a variety of health and nutritional conditions including heart and bone health, antioxidant detoxification function, insulin sensitivity, inflammation, obesity, Alzheimer's disease, hepatitis C, blood disorders, and oncology.

Marligen's (Ijamsville, MD, USA) Signet genotyping products and services are designed to rapidly and accurately detect genetic variations including single nucleotide polymorphisms (SNPs), small insertions and deletions (indels), and whole gene deletions. More...


The Signet genotyping assays are configured to be used in conjunction with the Luminex (Austin, TX, USA) xMAP System for multiplexed analysis. For investigators who do not have access to the Luminex instrumentation or who would prefer to outsource the work, the Signet technical staff also provides testing services. Information is available about adaptation for use on other platforms.

The high-throughput format allows hundreds of samples to be analyzed in one day. The standardized assay methodology and filter-plate format maximizes reproducibility. The solution is cost-effective and detects multiple genetic variants in one sample. It provides excellent allelic discrimination with yields of >99 % accuracy.

The flexible assay format allows individual assays in Signet genotyping panels to be configured into customized genotyping panels. For example, ten SNPs from five different panels can be reconfigured into a single customized panel. To configure a personalized custom panel, choose as many assays as needed from the full assay list and send the list to Marligen. The company's scientists will reconfigure the panels to your specifications, manufacture reagents, validate performance, and send you a complete package ready for use.

Luminex's xMAP technology is built on flow cytometry, microspheres, lasers, digital signal processing, and traditional chemistry. Featuring a flexible, open-architecture design, xMAP technology can be configured to perform a wide variety of bioassays quickly, cost-effectively, and accurately.

Related Links:
Marligen
Luminex



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
New
Automated Coagulation Analyzer
Hemolumi H6
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Originally designed for lung cancer detection and resistance monitoring, the test also shows potential for identifying signals linked to pulmonary fibrosis (image credit: iStock)

Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively

Lung cancer remains difficult to monitor for early progression and treatment resistance, while pulmonary fibrosis continues to pose major challenges for early diagnosis. Clinicians need repeatable, noninvasive... Read more

Microbiology

view channel
Image: The findings suggest that people with mpox can transmit the virus even without clinical symptoms (image credit: Adobe Stock)

Study Finds Hidden Mpox Infections May Drive Ongoing Spread

Mpox continues to circulate despite vaccination, and many cases show no known link to a symptomatic partner. The role of people without symptoms has remained uncertain, limiting clarity on how transmission persists.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.